Pfizer wins bid to invalidate GSK's patents over RSV vaccine
Pfizer on Monday won a bid in a London court to invalidate two of GSK's patents relating to a respiratory syncytial virus ...
Pfizer Stock Slump: Will Starboard's Billion-Dollar Bet Spark Rebound?
Pfizer's stock has struggled due to declining demand for COVID-19 treatments, but activist investor Starboard's $1 billion ...
Pfizer faces pressure as activist investor Starboard Value takes $1 billion stake
Activist investor Starboard Value has acquired a $1 billion stake in Pfizer, urging the company to improve its performance.
Starboard's stake in Pfizer 'doesn't make any sense to me at all', says Dartmouth's Paul Argenti
Paul Argenti, Dartmouth Tuck School of Business professor, joins 'Squawk Box' to discuss news of activist investor Starboard Value amassing a roughly $1 billion stake in drugmaker Pfizer, whether ...
Pfizer Gets an Activist. What Starboard’s Track Record With Pharma Tells Us.
Starboard has approached two former Pfizer executives, Ian Read and Frank D’Amelio, to assist in its efforts, and they have ...
Earnings Kickoff And World Conflicts Highlight The Week
A stronger than expected jobs report on Friday further eased fears of a slowing economy and allowed markets to stage ...
Hong Kong and Japan shares rally after U.S. jobs report
Hong Kong shares jumped again, rising 1.60% the day before mainland China markets reopen. Beijing said it would explain the ...
Why Goldman Sachs has bumped up its S&P 500 target for the third time this year
A team led by David Kostin made at least their third upgrade to S&P 500 forecasts this year. They now expect the S&P 500 SPX to reach 6,000 in three months' time, versus 5,600 previously, and 6,300 in ...
kffhealthnews45m
Out Of The Trash Bin: How Cobenfy’s Unusual Journey Could Change Pharma
Bristol Myers Squibb's schizophrenia drug, which received FDA approval last week, took a long and winding road to get there. Three decades ago, Eli Lilly developed the drug's forerunner, xanomeline, ...